A petition launched on Change.org by an Arizona veteran has gathered over 100,000 signatures in support of Dr. Sue Sisley’s efforts to initiate medical marijuana research in Arizona. Launched on …
On July 28, 2014, the University of Arizona denied Dr. Sue Sisley’s administrative appeal for reinstatement (view the letter). Update (July 31, 2014): The Arizona Board of Regents has announced that …
On Tuesday, July 22, at 12:00 pm, a group of veterans will assemble at the University of Arizona College of Medicine-Phoenix to demand the reinstatement of Dr. Sue Sisley, which will enable FDA-approved …
MAPS “PRESS RELEASE: Letter from Rick Doblin to University of Arizona in Support of Dr. Sue Sisley” On July 11, 2014, MAPS Founder Rick Doblin, Ph.D., wrote to Caroline Garcia, Associate Vice …
MAPS, DPA On Wednesday, June 11, the Multidisciplinary Association for Psychedelic Studies (MAPS) and the Drug Policy Alliance (DPA) will hold a press teleconference to accompany the release of their new …
Funding for research into the therapeutic uses of psychedelics and medical marijuana increased significantly this April, when the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) …
After 22 years of hard-fought efforts, the non-profit pharmaceutical company Multidisciplinary Association for Psychedelic Studies (MAPS) has finally obtained approval from the U.S. Department of Health …
On March 14, 2014, in an historic shift in federal policy, the U.S. Department of Health and Human Services granted permission for researchers to purchase research-grade marijuana from the National Institute …
Seeking new therapies for the treatment of social anxiety in autistic adults, researchers at the Los Angeles Biomedical Research Institute (LA BioMed) announced today that they are initiating a novel study …
Los Angeles Biomedical Research Institute and MAPS: Study Initiated Exploring MDMA-Assisted Therapy for Social Anxiety in Autistic Adults. Seeking new therapies for the treatment of social anxiety in autistic …
On March 4, 2014, the results of the first study of the therapeutic use of lysergic acid diethylamide (LSD) in humans in over 40 years were published online in the peer-reviewed Journal of Nervous and …
A Food and Drug Administration (FDA) and University of Arizona Institutional Review Board (IRB)-approved protocol for a study of marijuana for symptoms of PTSD in U.S. veterans, sponsored by the non-profit …
